Clinical Trial Update: Peanut Oral Immunotherapy in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating peanut oral immunotherapy in children for peanut hypersensitivity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Hypersensitivity

Drugs mentioned

• Peanut oral immunotherapy (peanut OIT)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Peanut Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2020-01-22